MCL

AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
Clinical Trials Arena
Mon, 06/17/24 - 11:21 am
AstraZeneca
clinical trials
Calquence
MCL
mantle cell lymphoma
ASCO: J&J, AbbVie go back to Imbruvica's roots in lymphoma. Will lack of survival win matter?
Fierce Pharma
Fri, 06/3/22 - 10:27 am
AbbVie
JNJ
ASCO 2022
FDA
Imbruvica
MCL
Rare Blood Disease Drug Win Marks Fourth Approval for Blueprint Medicines
BioSpace
Thu, 06/17/21 - 10:55 am
Blueprint Medicines
Ayvakit
MCL
systemic mastocytosis
FDA